Epigenetic Signatures in Metabolic Health and Cancer

A special issue of Epigenomes (ISSN 2075-4655).

Deadline for manuscript submissions: 30 April 2026 | Viewed by 54

Special Issue Editor


E-Mail Website1 Website2
Guest Editor
Biomedical and Clinical Science Research Theme, School of Science, University of Derby, Derby DE22 1GB, UK
Interests: epigenetics; type 2 diabetes; biomarker discovery; metabolic diseases

Special Issue Information

Dear Colleagues, 

This Special Issue focuses on the epigenetic signatures associated with metabolic health and cancer. These epigenetic signatures are potential companion diagnostic biomarkers, which can aid in the prediction of disease risk or cancer prognosis. We invite articles related to epigenetics in the subject area of diabetes research, obesity, cardiovascular diseases, and various types of cancer. Articles related to gene–environment interaction and cancer disease risk prediction will be considered. Understanding and elucidating the molecular signatures and pathways associated with metabolic health recovery and cancer diagnosis/prognosis would be the key purpose of this Special Issue.

Dr. Aparna Duggirala
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Epigenomes is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • DNA methylation
  • miRNA and gene targets
  • histone modifications
  • RNA methylation
  • molecular pathways
  • metabolic health
  • cancer
  • chromatin remodeling

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop